Price$5.45-2.48 (-31.27%)
2026-03-022026-06-03
News · 26 weeks19+700%
2025-12-072026-05-31
Mix1790d
- Insider13(76%)
- Other3(18%)
- SEC Filings1(6%)
Latest news
25 items- PR111, Inc. Announces First Quarter 2026 Unaudited Financial ResultsContinuing Transition toward a More Asset-Light and Operationally Efficient Business ModelNet Revenue of Promotional Products (1) Increased by 70.2% and Gross Profit Rose by 75.0% Year-over-YearTotal Marketplace (MP) Service Revenue Increased by 24.7% Year-over-YearFulfillment Expenses as a Percentage of Revenue Improved by 10 Basis Points Year-over-YearSHANGHAI, June 4, 2026 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ:YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced its unaudited financial results for the first quarter ended March
- INSIDERDirector Luo Jun Justin was granted 810,271 units of RSUs and sold $25,516 worth of RSUs (99,720 units at $0.26) (SEC Form 4) to cover taxes4 - 111, Inc. (0001738906) (Issuer)
- INSIDERDirector Sun Jian David was granted 810,271 units of RSUs and sold $25,516 worth of RSUs (99,720 units at $0.26) (SEC Form 4) to satisfy withholding obligation4 - 111, Inc. (0001738906) (Issuer)
- INSIDERDirector Chen Yang Luke was granted 594,222 units of RSUs and sold $1,239 worth of RSUs (4,840 units at $0.26) (SEC Form 4) to satisfy withholding tax4 - 111, Inc. (0001738906) (Issuer)
- INSIDERDirector Teo Nee Chuan gave a grant of 811,889 units of RSUs, increasing direct ownership by 1,931% to 811,889 units (SEC Form 4)4 - 111, Inc. (0001738906) (Issuer)
- INSIDERDirector Chen Yang Luke gave a grant of 594,222 units of RSUs, increasing direct ownership by 135% to 594,222 units (SEC Form 4)4 - 111, Inc. (0001738906) (Issuer)
- INSIDERDirector Luo Jun Justin gave a grant of 810,271 units of RSUs, increasing direct ownership by 2,106% to 810,271 units (SEC Form 4)4 - 111, Inc. (0001738906) (Issuer)
- INSIDERDirector Sun Jian David gave a grant of 810,271 units of RSUs, increasing direct ownership by 2,106% to 810,271 units (SEC Form 4)4 - 111, Inc. (0001738906) (Issuer)
- SECSEC Form 20-F filed by 111 Inc.20-F - 111, Inc. (0001738906) (Filer)
- SECSEC Form 6-K filed by 111 Inc.6-K - 111, Inc. (0001738906) (Filer)
- PR111, Inc. Announces Fourth Quarter and Fiscal Year 2025 Financial ResultsContinuing Transition to an Asset-Light Business Model to Improve Overall EfficiencyDelivered Non-GAAP Operating Profitability in Both Q4'25 and FY'25Generated Positive Operating Cash Flow for Both Q4'25 and FY'25Continued Gross Profit Margin Expansion for B2B Business in Both Q4'25 and FY'25SHANGHAI, April 9, 2026 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ:YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025. 2025 Executing Strategic Optimiz
- INSIDERSEC Form 3 filed by new insider Teo Nee Chuan3 - 111, Inc. (0001738906) (Issuer)
- INSIDERSEC Form 3 filed by new insider Luo Jun Justin3 - 111, Inc. (0001738906) (Issuer)
- INSIDERSEC Form 3 filed by new insider Sun Jian David3 - 111, Inc. (0001738906) (Issuer)
- INSIDERSEC Form 3 filed by new insider Chen Yang Luke3 - 111, Inc. (0001738906) (Issuer)
- INSIDERSEC Form 3 filed by 111 Inc.3 - 111, Inc. (0001738906) (Issuer)
- INSIDERSEC Form 3 filed by 111 Inc.3 - 111, Inc. (0001738906) (Issuer)
- SECSEC Form 6-K filed by 111 Inc.6-K - 111, Inc. (0001738906) (Filer)
- PR111, Inc. Announces Third Quarter 2025 Unaudited Financial ResultsTransition from An Asset-Heavy Business Model to An Asset-Light Business ModelAchieved Quarterly Non-GAAP Net ProfitabilityMaintained Non-GAAP Operational Profitability for Three Consecutive QuartersAchieved Quarterly Positive Operating Cash FlowSHANGHAI, Dec. 17, 2025 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ:YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced its unaudited financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Highlights Total operating expenses were RMB180.3 million (US$25.3 million)
- SECSEC Form 6-K filed by 111 Inc.6-K - 111, Inc. (0001738906) (Filer)
- PR111, Inc. Announces Second Quarter 2025 Unaudited Financial ResultsMaintained Quarterly Operational ProfitabilityOperating Expenses as a Percentage of Revenues Decreased 20 Basis Points YoYMaintained Positive Operating Cash Flow in the First Half of the YearSHANGHAI, Sept. 17, 2025 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ:YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced its unaudited financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Highlights Total operating expenses were RMB185.3 million (US$25.9 million), an improvement of 9.3% compared to RMB204.3 million in
- SECAmendment: SEC Form 20-F/A filed by 111 Inc.20-F/A - 111, Inc. (0001738906) (Filer)
- SECSEC Form 6-K filed by 111 Inc.6-K - 111, Inc. (0001738906) (Filer)
- PR111, Inc. Announces First Quarter 2025 Unaudited Financial ResultsMaintained Quarterly Operational ProfitabilityOperating Expenses as a Percentage of Revenues Decreased 30 Basis Points YoYMaintained Quarterly Positive Operating Cash FlowSHANGHAI, June 19, 2025 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ:YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced its unaudited financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights Net revenues were RMB3.5 billion (US$486.3 million), remaining relatively flat compared to the same quarter last year.Total operating expenses
- SECSEC Form 20-F filed by 111 Inc.20-F - 111, Inc. (0001738906) (Filer)
YI FAQ
6 questionsWhat does 111 Inc. do?
111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services, such as online consultation services and e-prescription services to consumers. Its product portfolio comprises prescription and over-the counter drugs, such as western and traditional Chinese medicinal drugs; nutritional supplements, such as vitamins and dietary products; contact...Where does YI stock trade?
111 Inc. (YI) is listed on NASDAQ.What sector and industry is YI in?
111 Inc. operates in the Consumer Staples sector, Retail-Drug Stores and Proprietary Stores industry.When did 111 Inc. go public?
111 Inc. (YI) completed its IPO in 2018.What companies are similar to YI?
Notable peers in the same industry include CVS (CVS Health Corporation), WBA (Walgreens Boots Alliance Inc.), GRDN (Guardian Pharmacy Services Inc.), RAD (Rite Aid Corporation), MDVL (MedAvail Holdings Inc.). Compare YI side-by-side with any of them on Quantisnow.How can I track YI on Quantisnow?
Quantisnow aggregates 111 Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow YI to receive live email and push alerts on every new disclosure.